The Asian Scientist 100
Lu Ke
Institution
Chinese Academy of Sciences
Country
China
Field
Materials Sciences
Lu is the winner of the 2020 Future Science Prize (Physical Science Prize) for discovering and synthesizing a superior nanotwinned structure and gradient nanostructure.
(Photo: Future Science Prize)
AWARDS
- Future Science Prize 2020
Related articles
Curcumin Curry Spice Could Suppress Inflammation In Tendinitis, Arthritis
A common culinary spice found in Indian curries could offer hope for sufferers of the painful condition tendinitis, which causes pain and tenderness near to joints.
Human Forebrains Show Dramatic Increase In White Matter, Chimps Don’t
Both chimpanzees and humans are born with immature prefrontal cortexes. However, while human infants show a dramatic increase in the volume of prefrontal white matter, baby chimpanzees don't.
Bohai Pharmaceuticals Acquires TCM Company, Yantai Tianzheng
Bohai Pharmaceuticals Group, Inc. announced this week the acquisition of Yantai Tianzheng Pharmaceutical Co., Ltd., another traditional Chinese medicine company in China.
Shanghai Jiaotong Releases 2011 Academic Rankings: US Colleges Dominate
US colleges dominated the 2011 ranking of world universities released by Shanghai's Jiaotong University today, with Harvard topping the list for the ninth year in a row.
Diarrhea-Causing Enterotoxin Receptor May Be Linked To ADHD
Chinese scientists have discovered that ADHD and other neuropsychiatric disorders may be caused by the abnormal function of a diarrhea-causing enterotoxin receptor.
Dr. Rossa Chiu, Chinese Uni. Of Hong Kong, Talks To Asian Scientist Magazine
We speak with CUHK's Prof. Rossa Chiu Wai Kwun, a doctor who has developed a safer, non-invasive technique for fetal genetic testing.
ADB Loans Indonesia US$100 Million For Sanitation & Infrastructure Projects
The Asian Development Bank will lend Indonesia US$100 million to finance basic infrastructure projects in rural villages.
Folate Intake May Lower Breast Cancer Risk In Premenopausal Women
A US-China joint study has shown that folate intake reduces the risk of breast cancer in premenopausal women by 40 percent.
Kyowa Kirin Starts Phase III Trial Of ARQ197/Erlotinib In NSC Lung Cancer
Kyowa Hakko Kirin is starting a Phase III trial evaluating the combination of ARQ 197 (tivantinib) and erlotinib in Asia for patients with advanced or metastatic non-small cell lung cancer.